Lilly Launches Foundayo in the UK as NICE Review Continues
Eli Lilly and Company (NYSE:LLY) has launched Foundayo in the United Kingdom, making Britain the first European country…
Encouraging trial results for AstraZeneca’s new weight-loss pill
PARIS — A new pill developed by the British pharma firm AstraZeneca appears to help people lose a…
LLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZeneca’s Therapies In Diabetes Trials
Lilly’s Foundayo outperformed existing treatments on blood sugar control and weight loss in type 2 diabetes patients in…